EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

LGR5: from stem cell marker to therapeutic target

Peyton C High, Maya G Cappellino, Tiffani A Blackburn, Kendra S Carmon

Trends in Cancer · 2026

DOI: 10.1016/j.trecan.2026.02.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2026. Verfasst von Peyton C High und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston,…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Neoplastic Stem Cells, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Council on Ocean Affairs Science and Technology, California State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is an established marker of normal and cancer stemlike cells. LGR5 has been implicated in promoting cancer cell plasticity that drives tumorigenesis, metastasis, and therapeutic resistance. LGR5 rapidly and constitutively internalizes and potentiates Wnt (Wingless/Int-1)/β-catenin and adhesion signaling pathways, though its precise mechanisms and interacting partners remain unresolved. An improved understanding of LGR5 signaling may provide invaluable insight into its intricate and important functions in cancer progression. Moreover, several LGR5-targeting therapies, including peptibody- and antibody-drug conjugates and bispecific antibodies, are showing promising efficacy and tolerability in colorectal cancer and other tumor types. This review discusses the cancer-related functions of LGR5 and explores the preclinical and clinical approaches to therapeutically target this enigmatic protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledNeoplastic Stem CellsBiomarkers, TumorNeoplasmsHumansAnimalsWnt Signaling PathwayMolecular Targeted TherapyAntineoplastic AgentsImmunoconjugatesColorectal Neoplasms

Stichwörter der Autor:innen

LGR5Wnt/β-catenin signalingantibody–drug conjugatebispecific antibodycancer cell plasticitycolorectal cancer

Substanzen

Receptors, G-Protein-CoupledLGR5 protein, humanBiomarkers, TumorAntineoplastic AgentsImmunoconjugates

Autor:innen und Institutionen

  • Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Ce…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Council on Ocean Affairs Science and Technology, California State University
  • National Institutes of Health
  • University of Texas MD Anderson Cancer Center
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

High, P. C., Cappellino, M. G., Blackburn, T. A., & Carmon, K. S. (2026). LGR5: from stem cell marker to therapeutic target. Trends in Cancer. https://doi.org/10.1016/j.trecan.2026.02.006

Vancouver

High PC, Cappellino MG, Blackburn TA, Carmon KS. LGR5: from stem cell marker to therapeutic target. Trends in Cancer. 2026. doi:10.1016/j.trecan.2026.02.006

BibTeX
@article{High2026,
  author = {High, Peyton C and Cappellino, Maya G and Blackburn, Tiffani A and Carmon, Kendra S},
  title = {LGR5: from stem cell marker to therapeutic target},
  journal = {Trends in Cancer},
  year = {2026},
  doi = {10.1016/j.trecan.2026.02.006}
}
Kostenlos starten →